Is cartilage sGAG content related to early changes in cartilage disease? Implications for interpretation of dGEMRIC

Osteoarthritis and Cartilage

Volumn 20, Issue 5, 2012, Pages 396-404

  Stubendorff, J J ^a   Lammentausta, E ^a,b   Struglics, A ^c   Lindberg, L ^a   Heinegard D ^c   Dahlberg, L E ^a  

^a LUND UNIVERSITY   (Sweden)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c LUND UNIVERSITY   (Sweden)

Author keywords

DGEMRIC; OA cartilage; SGAG content

Indexed keywords

AGGRECAN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN FIBER; GADODIAMIDE; GADOLINIUM PENTETATE; GLYCOSAMINOGLYCAN; HYDROXYPROLINE; SULPHATED GLYCOSAMINOGLYCAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARTILAGE MATRIX; CHEMICAL ANALYSIS; CHONDROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMUR NECK FRACTURE; HIP OSTEOARTHRITIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; CONTRAST MEDIA; EARLY DIAGNOSIS; FEMORAL NECK FRACTURES; FEMUR HEAD; GADOLINIUM DTPA; GLYCOSAMINOGLYCANS; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOPOROTIC FRACTURES;

EID: 84859424798     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.01.015     Document Type: Article

References (50)

1. Heinegard D. Proteoglycans and more - from molecules to biology. Int J Exp Pathol 2009, 90:575-586.
2. Maroudas A., Venn M. Chemical composition and swelling of normal and osteoarthrotic femoral head cartilage. II. Swelling. Ann Rheum Dis 1977, 36:399-406.
3. Maroudas A.I. Balance between swelling pressure and collagen tension in normal and degenerate cartilage. Nature 1976, 260:808-809.
4. Halasz K., Kassner A., Morgelin M., Heinegard D. COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem 2007, 282:31166-31173.
5. Rosenberg K., Olsson H., Morgelin M., Heinegard D. Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem 1998, 273:20397-20403.
6. Heathfield T.F., Onnerfjord P., Dahlberg L., Heinegard D. Cleavage of fibromodulin in cartilage explants involves removal of the N-terminal tyrosine sulfate-rich region by proteolysis at a site that is sensitive to matrix metalloproteinase-13. J Biol Chem 2004, 279:6286-6295.
7. Fosang A.J., Rogerson F.M., East C.J., Stanton H. ADAMTS-5: the story so far. Eur Cell Mater 2008, 15:11-26.
8. Larsson S., Lohmander L.S., Struglics A. Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study. Arthritis Res Ther 2009, 11. R92.
9. Struglics A., Larsson S., Pratta M.A., Kumar S., Lark M.W., Lohmander L.S. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarthritis Cartilage 2006, 14:101-113.
10. Mansson B., Carey D., Alini M., Ionescu M., Rosenberg L.C., Poole A.R., et al. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 1995, 95:1071-1077.
11. Sharif M., Saxne T., Shepstone L., Kirwan J.R., Elson C.J., Heinegard D., et al. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol 1995, 34:306-310.
12. Bashir A., Gray M.L., Burstein D. Gd-DTPA2- as a measure of cartilage degradation. Magn Reson Med 1996, 36:665-673.
13. Maroudas A., Muir H., Wingham J. The correlation of fixed negative charge with glycosaminoglycan content of human articular cartilage. Biochim Biophys Acta 1969, 177:492-500.
14. Maroudas A. Physicochemical properties of cartilage in the light of ion exchange theory. Biophys J 1968, 8:575-595.
15. Bashir A., Gray M.L., Hartke J., Burstein D. Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI. Magn Reson Med 1999, 41:857-865.
16. Ericsson Y.B., Tjornstrand J., Tiderius C.J., Dahlberg L.E. Relationship between cartilage glycosaminoglycan content (assessed with dGEMRIC) and OA risk factors in meniscectomized patients. Osteoarthritis Cartilage 2009, 17:565-570.
17. Owman H., Tiderius C.J., Neuman P., Nyquist F., Dahlberg L.E. Association between findings on delayed gadolinium-enhanced magnetic resonance imaging of cartilage and future knee osteoarthritis. Arthritis Rheum 2008, 58:1727-1730.
18. Tiderius C.J., Olsson L.E., Leander P., Ekberg O., Dahlberg L. Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis. Magn Reson Med 2003, 49:488-492.
19. Adams M.E., Brandt K.D. Hypertrophic repair of canine articular cartilage in osteoarthritis after anterior cruciate ligament transection. J Rheumatol 1991, 18:428-435.
20. Lorenzo P., Bayliss M.T., Heinegard D. Altered patterns and synthesis of extracellular matrix macromolecules in early osteoarthritis. Matrix Biol 2004, 23:381-391.
21. Matyas J.R., Ehlers P.F., Huang D., Adams M.E. The early molecular natural history of experimental osteoarthritis. I. Progressive discoordinate expression of aggrecan and type II procollagen messenger RNA in the articular cartilage of adult animals. Arthritis Rheum 1999, 42:993-1002.
22. Lorenz H., Wenz W., Ivancic M., Steck E., Richter W. Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading. Arthritis Res Ther 2005, 7:R156-R165.
23. Mankin H.J., Lippiello L. The glycosaminoglycans of normal and arthritic cartilage. J Clin Invest 1971, 50:1712-1719.
24. Maroudas A. Glycosaminoglycan turn-over in articular cartilage. Philos Trans R Soc Lond B Biol Sci 1975, 271:293-313.
25. Grushko G., Schneiderman R., Maroudas A. Some biochemical and biophysical parameters for the study of the pathogenesis of osteoarthritis: a comparison between the processes of ageing and degeneration in human hip cartilage. Connect Tissue Res 1989, 19:149-176.
26. Yagi R., McBurney D., Laverty D., Weiner S., Horton W.E. Intrajoint comparisons of gene expression patterns in human osteoarthritis suggest a change in chondrocyte phenotype. J Orthop Res 2005, 23:1128-1138.
27. Karlsson M., Bjornsson S. Quantitation of proteoglycans in biological fluids using Alcian blue. Methods Mol Biol 2001, 171:159-173.
28. Saxne T., Heinegard D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 1992, 31:583-591.
29. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
30. Struglics A., Larsson S., Hansson M., Lohmander L.S. Western blot quantification of aggrecan fragments in human synovial fluid indicates differences in fragment patterns between joint diseases. Osteoarthritis Cartilage 2009, 17:497-506.
31. Struglics A., Hansson M. Calpain is involved in C-terminal truncation of human aggrecan. Biochem J 2010, 430:531-538.
32. Lark M.W., Gordy J.T., Weidner J.R., Ayala J., Kimura J.H., Williams H.R., et al. Cell-mediated catabolism of aggrecan. Evidence that cleavage at the " aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain. J Biol Chem 1995, 270:2550-2556.
33. Stegemann H., Stalder K. Determination of hydroxyproline. Clin Chim Acta 1967, 18:267-273.
34. Bank R.A., Krikken M., Beekman B., Stoop R., Maroudas A., Lafeber F.P., et al. A simplified measurement of degraded collagen in tissues: application in healthy, fibrillated and osteoarthritic cartilage. Matrix Biol 1997, 16:233-243.
35. Prophet EB, Mills, B., Arrington, JB, Sobin, LH., editor. Laboratory Methods in Histotechnology. Washington, 1992.
36. Mankin H.J., Dorfman H., Lippiello L., Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971, 53:523-537.
37. Multanen J., Rauvala E., Lammentausta E., Ojala R., Kiviranta I., Hakkinen A., et al. Reproducibility of imaging human knee cartilage by delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) at 1.5 Tesla. Osteoarthritis Cartilage 2009, 17:559-564.
38. Venn M., Maroudas A. Chemical composition and swelling of normal and osteoarthrotic femoral head cartilage. I. Chemical composition. Ann Rheum Dis 1977, 36:121-129.
39. Maroudas A., Evans H., Almeida L. Cartilage of the hip joint. Topographical variation of glycosaminoglycan content in normal and fibrillated tissue. Ann Rheum Dis 1973, 32:1-9.
40. Squires G.R., Okouneff S., Ionescu M., Poole A.R. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Arthritis Rheum 2003, 48:1261-1270.
41. Allen R.G., Burstein D., Gray M.L. Monitoring glycosaminoglycan replenishment in cartilage explants with gadolinium-enhanced magnetic resonance imaging. J Orthop Res 1999, 17:430-436.
42. Williams A., Oppenheimer R.A., Gray M.L., Burstein D. Differential recovery of glycosaminoglycan after IL-1-induced degradation of bovine articular cartilage depends on degree of degradation. Arthritis Res Ther 2003, 5:R97-R105.
43. Bank R.A., Soudry M., Maroudas A., Mizrahi J., TeKoppele J.M. The increased swelling and instantaneous deformation of osteoarthritic cartilage is highly correlated with collagen degradation. Arthritis Rheum 2000, 43:2202-2210.
44. Tortorella M.D., Liu R.Q., Burn T., Newton R.C., Arner E. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol 2002, 21:499-511.
45. Nagase H., Kashiwagi M. Aggrecanases and cartilage matrix degradation. Arthritis Res Ther 2003, 5:94-103.
46. Ilic M.Z., Handley C.J., Robinson H.C., Mok M.T. Mechanism of catabolism of aggrecan by articular cartilage. Arch Biochem Biophys 1992, 294:115-122.
47. Tiderius C., Hori M., Williams A., Sharma L., Prasad P.V., Finnell M., et al. dGEMRIC as a function of BMI. Osteoarthritis Cartilage 2006, 14:1091-1097.
48. Kulmala K.A., Korhonen R.K., Julkunen P., Jurvelin J.S., Quinn T.M., Kroger H., et al. Diffusion coefficients of articular cartilage for different CT and MRI contrast agents. Med Eng Phys 2010, 32:878-882.
49. Silvast T.S., Jurvelin J.S., Lammi M.J., Toyras J. pQCT study on diffusion and equilibrium distribution of iodinated anionic contrast agent in human articular cartilage - associations to matrix composition and integrity. Osteoarthritis Cartilage 2009, 17:26-32.
50. Lammentausta E., Kiviranta P., Nissi M.J., Laasanen M.S., Kiviranta I., Nieminen M.T., et al. T2 relaxation time and delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) of human patellar cartilage at 1.5 T and 9.4 T: relationships with tissue mechanical properties. J Orthop Res 2006, 24:366-374.